▲

For the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement

Video Library

Important Safety Information and Indications

+

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

OTIPRIO (ciprofloxacin otic suspension) 6% is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components of OTIPRIO

Video Library

OTIPRIO preparation video - See how OTIPRIO is prepared for administration by watching the instructional video

See how Otiprio works

Watch the method of action video and learn about the proprietary technology of OTIPRIO

OTIPRIO® (ciprofloxacin otic suspension) 6%

 
OTIPRIO preparation video - See how OTIPRIO is prepared for administration by watching the instructional video

Otiprio Preparation Video

See how OTIPRIO is prepared for administration by watching the instructional video

ENT administered at the time of ear tube placement gives you assured compliance in a single dose

 
OTIPRIO preparation video - See how OTIPRIO is prepared for administration by watching the instructional video

Thermosensitive Video

Learn how OTIPRIO transitions from a liquid to gel

OTIPRIO® has thermosensitive properties that allow it to transition from a liquid to a gel when warmed

OTIPRIO preparation video - See how OTIPRIO is prepared for administration by watching the instructional video

Otiprio Administration

Through the tube

Watch a video showing an ENT administer OTIPRIO through an ear tube

 
OTIPRIO preparation video - See how OTIPRIO is prepared for administration by watching the instructional video

Otiprio Administration

Through myringotomy

Watch a video showing an ENT administer OTIPRIO through an incision followed by a tube placement

 
OTIPRIO preparation video - See how OTIPRIO is prepared for administration by watching the instructional video

Otiprio Administration

Through second incision

Watch a video showing an ENT administer OTIPRIO through a second incision

IMPORTANT SAFETY INFORMATION

CONTRAINDICATONS

OTIPRIO (ciprofloxacin otic suspension) 6% is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components of OTIPRIO

WARNINGS AND PRECAUTIONS

Potential for Microbial Overgrowth: OTIPRIO may result in overgrowth of non-susceptible bacteria and fungi. If such infections occur, institute alternative therapy.

ADVERSE REACTIONS

Bilateral otitis media with effusion clinical trials: Adverse reactions (incidence at least 3%) with OTIPRIO vs sham were: nasopharyngitis (5% vs 4%), irritability (5% vs 3%), and rhinorrhea (3% vs 2%).

Acute otitis externa clinical trial: Adverse reactions (incidence at least 2%) with OTIPRIO vs sham were: ear pruritus (2% vs 2%), headache (2% vs 1%), otitis media (2% vs 1%), and ear discomfort (2% vs 0%).

USE IN SPECIFIC POPULATIONS

Pediatric Use: The safety and effectiveness of OTIPRIO in infants below six months of age have not been established for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement and acute otitis externa.

INDICATIONS AND USAGE

OTIPRIO (ciprofloxacin otic suspension) 6% is a fluoroquinolone antibacterial indicated for:

  • The treatment of pediatric patients (6 months of age and older) with bilateral otitis media with effusion undergoing tympanostomy tube placement
  • The treatment of acute otitis externa in patients 6 months of age and older due to Pseudomonas aeruginosa and Staphylococcus aureus